Literature DB >> 15718553

Selective serotonin reuptake inhibitors: placebo washouts inflate antidepressant effects in general practice.

Harm W J van Marwijk, Herman J Adèr.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15718553      PMCID： PMC549150          DOI： 10.1136/bmj.330.7488.420-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Selective serotonin reuptake inhibitors.

Authors:  John R Geddes; Andrea Cipriani
Journal:  BMJ       Date:  2004-10-09

2.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

3.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

Authors:  K F Schulz; I Chalmers; R J Hayes; D G Altman
Journal:  JAMA       Date:  1995-02-01       Impact factor: 56.272

Review 4.  Active placebos versus antidepressants for depression.

Authors:  J Moncrieff; S Wessely; R Hardy
Journal:  Cochrane Database Syst Rev       Date:  2004

5.  Meta-analysis of placebo rates in major depressive disorder trials.

Authors:  Pieter Stolk; Maarten J Ten Berg; Michiel E H Hemels; Thomas R Einarson
Journal:  Ann Pharmacother       Date:  2003-12       Impact factor: 3.154
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.